Recurrence of Sipple syndrome

Background. Multiple endocrine neoplasia (MEN) 2A is a rare autosomal dominant genetic syndrome that is often misdiagnosed or clinically ignored, resulting in delayed treatment of patients. It is predominantly a hereditary disease with a prevalence of 1 per 40,000 people. In half of the cases, MEN syndrome occurs sporadically and is caused by a new mutation in germ or somatic cells. Aim: to improve diagnosis and differential diagnosis of diseases that occur with hypertension, timely diagnosis and appropriate treatment of patients. Materials and methods. We presented a case of diagnosis, treatment and postoperative observation of a patient with recurrence of Sipple syndrome. Results. A 44-year-old man had main complaint of recurrences of hypertensive crises 9 years after diagnosis and treatment for MEN 2A syndrome. A feature of this clinical case was the differential diagnosis of diseases that occur with hypertension to make the correct diagnosis. Conclusions. Patients with MEN syndrome after surgical treatment require careful monitoring throughout life for timely diagnosis and treatment of disease recurrence. Also, an important aspect is genetic examination of family members for the presence of RET proto-oncogene mutations for the purpose of timely diagnosis and prevention of the development of MEN syndrome.

Authors

Institutions

Publication Details

Journal
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
Published
2025-05-22
DOI
https://doi.org/10.22141/2224-0721.21.3.2025.1547
Primary Topic
Myasthenia Gravis and Thymoma
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recurrence of Sipple syndrome

Alina Urbanovych, O. Safonova, А.S. Safonov, M.-Yu.Yu. Markevych et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
Myasthenia Gravis and Thymoma
article

Recurrence of Sipple syndrome

Alina Urbanovych, O. Safonova, А.S. Safonov, M.-Yu.Yu. Markevych, Yu.O. Markevych
article en

Abstract

Background. Multiple endocrine neoplasia (MEN) 2A is a rare autosomal dominant genetic syndrome that is often misdiagnosed or clinically ignored, resulting in delayed treatment of patients. It is predominantly a hereditary disease with a prevalence of 1 per 40,000 people. In half of the cases, MEN syndrome occurs sporadically and is caused by a new mutation in germ or somatic cells. Aim: to improve diagnosis and differential diagnosis of diseases that occur with hypertension, timely diagnosis and appropriate treatment of patients. Materials and methods. We presented a case of diagnosis, treatment and postoperative observation of a patient with recurrence of Sipple syndrome. Results. A 44-year-old man had main complaint of recurrences of hypertensive crises 9 years after diagnosis and treatment for MEN 2A syndrome. A feature of this clinical case was the differential diagnosis of diseases that occur with hypertension to make the correct diagnosis. Conclusions. Patients with MEN syndrome after surgical treatment require careful monitoring throughout life for timely diagnosis and treatment of disease recurrence. Also, an important aspect is genetic examination of family members for the presence of RET proto-oncogene mutations for the purpose of timely diagnosis and prevention of the development of MEN syndrome.

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)Vol. 21(3)
Danylo Halytsky Lviv National Medical University (UA), Triemli Hospital (CH), Lviv National Musical Academy named after Mykola Lysenko (UA)
Openalex Percentile: Top 81%
Myasthenia Gravis and Thymoma
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.